Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Sergio Gil-Manso"'
Autor:
Jorge Gallego-Valle, Verónica Astrid Pérez-Fernández, Jesús Rosales-Magallares, Sergio Gil-Manso, María Castellá, Europa Azucena Gonzalez-Navarro, Rafael Correa-Rocha, Manel Juan, Marjorie Pion
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionImmunotherapy has revolutionized cancer treatment, and Chimeric Antigen Receptor T cell therapy (CAR-T) is a groundbreaking approach. Traditional second-generation CAR-T therapies have achieved remarkable success in hematological malignan
Externí odkaz:
https://doaj.org/article/d613b6479ed44a07b48cd00d01b1c9e2
Autor:
Roberto Alonso, Sergio Gil-Manso, Pilar Catalán, Ignacio Sánchez-Arcilla, Marco Marzola, Rafael Correa-Rocha, Patricia Muñoz, Marjorie Pion, the Gregorio Marañón Microbiology-ID COVID-19 Study Group
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The development of mRNA vaccines represented a significant achievement in response to the global health crisis during the SARS-CoV-2 pandemic. Evaluating vaccine efficacy entails identifying different anti-SARS-CoV-2 antibodies, such as total antibod
Externí odkaz:
https://doaj.org/article/01e70eeca9024b2490ec99ce351d43ed
Autor:
Sergio Gil-Manso, Iria Miguens Blanco, Bruce Motyka, Anne Halpin, Rocío López-Esteban, Verónica Astrid Pérez-Fernández, Diego Carbonell, Luis Andrés López-Fernández, Lori West, Rafael Correa-Rocha, Marjorie Pion
Publikováno v:
Virulence, Vol 13, Iss 1, Pp 30-45 (2022)
Since December 2019, the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread throughout the world. To eradicate it, it is crucial to acquire a strong and long-lasting anti-SARS-C
Externí odkaz:
https://doaj.org/article/b17bcd959ecb4f6fa0fb241230ed95e5
Autor:
Sergio Gil-Manso, Diego Herrero-Quevedo, Diego Carbonell, Marta Martínez-Bonet, Esther Bernaldo-de-Quirós, Rebeca Kennedy-Batalla, Jorge Gallego-Valle, Rocío López-Esteban, Elena Blázquez-López, Iria Miguens-Blanco, Rafael Correa-Rocha, Vanessa Gomez-Verdejo, Marjorie Pion
Publikováno v:
PLoS Pathogens, Vol 19, Iss 6, p e1011432 (2023)
BackgroundSARS-CoV-2 emerged as a new coronavirus causing COVID-19, and it has been responsible for more than 760 million cases and 6.8 million deaths worldwide until March 2023. Although infected individuals could be asymptomatic, other patients pre
Externí odkaz:
https://doaj.org/article/3a40055c19d54c08976f61ce3ad47d34
Autor:
Sergio Gil-Manso, Roberto Alonso, Pilar Catalán, Ignacio Sánchez-Arcilla, Marco Marzola, Rafael Correa-Rocha, Marjorie Pion, Patricia Muñoz, Gregorio Marañón Microbiology-ID COVID-19 Study Group, Luis Alcalá, Teresa Aldámiz, Beatriz Álvarez, Ana Álvarez-Uría, Alexi Arias, Elena Bermúdez, Emilio Bouza, Sergio Buenesta do-Serrano, Almudena Burillo, Raquel Carrillo, Emilia Cercenado, Alejandro Cobos, Cristina Díez, Pilar Escribano, Agustín Estévez, Chiara Fanciulli, Alicia Galar, Mª Dolores García, Darío García de Viedma, Paloma Gijón, Adolfo González, Helmuth Guillén, Jesús Guinea, Marta Herranz, Álvaro Irigoyen, Laura Vanessa Haces, Martha Kestler, Juan Carlos López, Carmen Narcisa Losada, Marina Machado, Mercedes Marín, Pablo Martín-Rabadán, Andrea Molero-Salinas, Pedro Montilla, Patricia Muñoz, María Olmedo, Belén Padilla, Rosalía Palomino-Cabrera, María Palomo, María Jesús Pérez-Granda, Daniel Peñas-Utrilla, Laura Pérez-Lago, Leire Pérez, Elena Reigadas, Cristina Rincón, Belén Rodríguez, Sara Rodríguez, Cristina Rodríguez-Grande, Adriana Rojas, María Jesús Ruiz-Serrano, Carlos Sánchez, Mar Sánchez, Amadeo Sanz-Pérez, Julia Serrano, Francisco Tejerina, Maricela Valerio, Mª Cristina Veintimilla, Lara Vesperinas, Teresa Vicente, Sofíade la Villa
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
IntroductionSince the COVID-19 outbreak, specific mRNA-based anti-SARS-CoV-2 vaccines have been developed and distributed worldwide. Because this is the first time that mRNA vaccines have been used, there are several questions regarding their capacit
Externí odkaz:
https://doaj.org/article/fb0bdcc4626442ab9011659a5c02ff37
Autor:
Alejandro Cenalmor, Elena Pascual, Sergio Gil-Manso, Rafael Correa-Rocha, José Ramón Suárez, Isabel García-Álvarez
Publikováno v:
Molecules, Vol 28, Iss 12, p 4882 (2023)
Neuroinflammation plays a crucial role in the progression of Alzheimer’s disease and other neurodegenerative disorders. Overactivated microglia cause neurotoxicity and prolong the inflammatory response in many neuropathologies. In this study, we ha
Externí odkaz:
https://doaj.org/article/d6470fef8f8b42b593662eb439799f16
Autor:
Sergio Gil-Manso, Iria Miguens Blanco, Rocío López-Esteban, Diego Carbonell, Luis Andrés López-Fernández, Lori West, Rafael Correa-Rocha, Marjorie Pion
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
SARS-CoV-2 has infected more than 200 million people worldwide, with more than 4 million associated deaths. Although more than 80% of infected people develop asymptomatic or mild COVID-19, SARS-CoV-2 can induce a profound dysregulation of the immune
Externí odkaz:
https://doaj.org/article/3be06fe1db8f47b9ba42fad576df7b7e
Autor:
Sergio Gil-Manso, Diego Carbonell, Luis López-Fernández, Iria Miguens, Roberto Alonso, Ismael Buño, Patricia Muñoz, Jordi Ochando, Marjorie Pion, Rafael Correa-Rocha
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
ObjectivesIn the context of the Covid-19 pandemic, the fast development of vaccines with efficacy of around 95% preventing Covid-19 illness provides a unique opportunity to reduce the mortality associated with the pandemic. However, in the absence of
Externí odkaz:
https://doaj.org/article/9776fd1f074644a49f808d9aff4151e3
Autor:
Sergio Gil-Manso, Diego Carbonell, Verónica Astrid Pérez-Fernández, Rocío López-Esteban, Roberto Alonso, Patricia Muñoz, Jordi Ochando, Ignacio Sánchez-Arcilla, Jose M Bellón, Rafael Correa-Rocha, Marjorie Pion
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1676 (2022)
Vaccination against SARS-CoV-2 has become the main method of reducing mortality and severity of COVID-19. This work aims to study the evolution of the cellular and humoral responses conferred by two mRNA vaccines after two doses against SARS-CoV-2. O
Externí odkaz:
https://doaj.org/article/abf825621e4742a88b7cff800b0109cc
Autor:
Jorge Gallego-Valle, Sergio Gil-Manso, Ana Pita, Esther Bernaldo-de-Quirós, Rocío López-Esteban, Marta Martínez-Bonet, Verónica Astrid Pérez-Fernández, Ramón Pérez-Caballero, Carlos Pardo, Juan-Miguel Gil-Jaurena, Rafael Correa-Rocha, Marjorie Pion
Publikováno v:
Biomedicines, Vol 9, Iss 5, p 461 (2021)
Regulatory T cells (Tregs), which are characterized by the expression of the transcription factor forkhead box P3 (FOXP3), are the main immune cells that induce tolerance and are regulators of immune homeostasis. Natural Treg cells (nTregs), describe
Externí odkaz:
https://doaj.org/article/c60ae1c53ea44599b9d312c68b0b8225